Trial
NCT02521753
Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Coordinación de Investigación en Salud, Mexico
Collaborators
—
Condition
Polycystic Ovary Syndrome
Intervention
Metformin
Why stopped
It was not possible to continue recruiting due to SARSCov2 pandemia. Results obtained at that time were already published
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-01